After the Duchess of Sussex announced her American Riviera Orchard rebrand, she once again is facing accusations of ...
Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
NEW YORK, NY / ACCESS Newswire / February 20, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...
Julie Levinson Werner and Sandra Halbing of Lowenstein Sandler discuss current DEI-related practices among businesses and ...
Palantir is gaining significant traction in the tech world with its AI-driven services, experiencing a dramatic stock ...
Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.
The transaction, expected to close in the first half of this year, will cost Novartis $925 million upfront with potential ...
Working with Merck, the researchers are now testing a similar kidney cancer vaccine in a randomized trial with 272 patients. In the meantime, Choueiri said, "We're very excited about these results." ...
Just don’t ask him which division the Rams are in or what their logo looks like. During his stroll through radio row at the Super Bowl on Wednesday, Nacua was asked by Sports Illustrated to draw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results